SignatureFD’s Cambria Cannabis ETF TOKE Stock Holding History

SignatureFD’s Portfolio TOKE Stock Details TOKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	-$2K	–	3354
2022 Q2	$2K	Buy	+200	New	+$1.91K	﹤0.01%	2812

Other funds holding TOKE

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cambridge Advisors Omaha, Nebraska $582M AUM 19.14% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

SignatureFD's TOKE Position: Q3 2022 in Review

SignatureFD sold out of Cambria Cannabis ETF (TOKE) in Q3 2022, closing a stake of 200 shares — an estimated $2K sold.

SignatureFD first reported a position in TOKE in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 23 funds tracked by Wall St. Rank hold TOKE as of Q3 2022.

SignatureFD reported no remaining Cambria Cannabis ETF position as of Q3 2022 after selling out during the quarter.
SignatureFD sold 200 Cambria Cannabis ETF shares in Q3 2022, an estimated $2K.
SignatureFD first reported a position in Cambria Cannabis ETF in Q2 2022 and held it in 1 quarter.
SignatureFD's Cambria Cannabis ETF position peaked at $2K in Q2 2022.
23 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q3 2022.

Based on SignatureFD's 13F filing for Q3 2022, filed 8 Nov 2022.